Company intelligence
Centerview Partners
About Centerview Partners
Centerview Partners is a premier provider of independent investment-banking advisory services. We forge long-term relationships to provide strategic advice to marquee companies around the world, with industry-leading expertise in M&A, independent board advice, special committees, shareholder activism, debt and equity financing, restructuring and recapitalization. A private, entrepreneurial firm with offices in New York, London, Paris, Menlo Park and San Francisco, we have advised clients on more than $4 trillion in transactions since our founding in 2006. For more information, please visit www.centerviewpartners.com. Member, SIPC. Please note: Posts of third-party content on this page do not reflect the views of Centerview Partners and have not been reviewed by Centerview Partners for completeness or accuracy.
Verified activity
Signals from Centerview Partners
4 published signals
Partnerships
Centerview Partners is acting as an exclusive financial advisor to the Lead Lenders in Loparex's out-of-court recapitalization with 100% creditor support.
Reported by Centerview Partners
Research & Knowledge
Centerview Partners co-authored an op-ed in the Washington Post co-authored by Robert Rubin and Henry Paulson regarding AI warfare, cyberattacks on financial systems, and a bioengineered pandemic.
Reported by Centerview Partners
Strategy & Corporate Development
Centerview Partners is serving as an exclusive financial advisor to Merida Biosciences on its sale to Eli Lilly and Company for up to $2.875 billion.
Reported by Centerview Partners
Strategy & Corporate Development
Centerview Partners acted as Exclusive Financial Advisor to Merida Biosciences for the acquisition of Eli Lilly and Company by Merida Biosciences for up to $2.875bn.
Reported by E. Eric Tokat